LeeAnne B. Sherwin, PhD, MS, FNP-BC

Assistant Professor

LeeAnne-Sherwin

 

E-mail: sherwinl@missouri.edu
Phone: 573.882.0295

S430 Sinclair School of Nursing
University of Missouri
Columbia, MO 65211

 

Graduate Faculty Status – Yes
DNP Doctoral Faculty Status – Yes
PhD Doctoral Faculty Status – Yes

 

Program of Research

Dr. Sherwin conducts clinical research focused on symptom science and the improvement of health and symptom-related outcomes in those who suffer from chronic gastrointestinal disorders across the lifespan.

 

Selected Grants, Honors and Awards
  • Developing and testing social support targeted messages to enhance medication adherence — Mizzou Alumni Association Richard Wallace Faculty Incentive Grant, 2021-2022
  • Engaging patients to optimize medication adherence — MU Center for Patient-Centered Outcomes Research, 2017-2018
  • Psychosocial Determinants of Rifaximin Adherence for the Treatment of Irritable Bowel Syndrome — MU Research Council, 2017-2018
  • National Institutes of Health Summer Research Mentor Award, National Institutes of Health, 2015
  • Intramural Research Training Award, National Institute of Nursing Research, National Institutes of Health 2013 – 2015 
  • The role of catastrophizing coping on health-related quality of life in adults with Irritable Bowel Syndrome, Gastroenterology Center of Connecticut, Hamden, CT, Sherwin, L (PI), 2012
  • Illness representations, catastrophizing coping, and health-related quality of life in adults with Irritable Bowel Syndrome, Grand Teton Gastroenterology Research Group, Idaho Falls, ID, Research Fellow Award, (Nail, PI), Sherwin, L (Co-I), 2012
  • Mid-Career Research Award, Self-Care Research Interest Group, Midwest Nursing Research Society, 2020
  • Excellence in Research Award, MU Nursing Alumni Association, 2019
  • Dean’s Dissertation Award, Oregon Health & Science University 2012
      •  

 

Selected Publications
  • Sherwin, L. B., Deroche, C. B., Yevu-Johnson, J., Matteson-Kome, M., Bechtold, M., Jahnke, I., & Alexander, G. L. (2021). Usability evaluation of a smartphone medication reminder application in patients treated with short-term antibiotic. CIN: Computers, Informatics, Nursing39(10), 547-553.
  • Sherwin, L. B., Deroche, C. B., Krisanabud, P., Matteson-Kome, M., Bechtold, M., & Ruppar, T. (2020). Adherence to short-course pharmacotherapy in adults with irritable bowel syndrome. Western journal of nursing research42(7), 524-534.
  • Sherwin, L. B., Ross, D., Matteson-Kome, M., Bechtold, M., Deroche, C., & Wakefield, B. (2020). Patient Perspectives on Short-Course Pharmacotherapy: Barriers and Facilitators to Medication Adherence. Journal of Patient Experience7(5), 726-733.
  • Kamp, K. J., Weaver, K. R., Sherwin, L. B., Barney, P., Hwang, S. K., Yang, P. L., … & Heitkemper, M. M. (2019). Effects of a comprehensive self-management intervention on extraintestinal symptoms among patients with IBS. Journal of Psychosomatic Research126, 109821.
  • Sherwin, LB, (2018). Laypersons’ knowledge and perceptions of irritable bowel syndrome as potential barriers to care. Journal of Advanced Nursing, Jan. 10. DOI: 10.1111/jan.13521 
  • Sherwin, LB, Ozoji, OM, Boulineux, CM, Jospeh, PV, Fourie, NH, Abey, SK, Zhang, X, & Henderson, WA. (2017). Gender and weight influence quality of life in irritable bowel syndrome, Journal of Clinical Medicine, 6(11), 103; DOI” 10.3390/jcm6110103
  • Sherwin, LB, Leary, E, & Henderson, WA. (2017). The association of catastrophizing with quality of life outcomes in patients with irritable bowel syndrome. Quality of Life Research, 26(8), 2161-2170. DOI: 10.1007/s11136-017-1554-0. Epub: March 21, 2017.
  • Abey, SK, Yuana, Y, Kenea, ND, Joseph, PV, Fourie, NH, Sherwin, LB, Gonye, GE, Smyser, PA, Stempinski, ES, Boulineaux, CM, & Henderson, WA. (2017). Lysozyme association with circulating RNA, extracellular vesicles and chronic stress. BBA Clinical 7, 23-35.
  • Abey, SK, Yuana, Y, Kenea, ND, Joseph, PV, Fourie, NH, Sherwin, LB, Gonye, GE, Smyser, PA, Stempinski, ES, Boulineaux, CM, & Henderson, WA. (2016). Data supporting the effects of lysozyme on mRNA and protein expression in a colon epithelial monolayer scratch wound model. Data in Brief, http://dx.doi.org/10.1016/j.dib.2016.12.043
  • Sherwin, LB, Leary, E, & Henderson, WA (2016). Effect of illness representations of catastrophizing on quality of life in adults with irritable bowel syndrome. Journal of Psychosocial Nursing and Mental Health Services, 54(9), 44-53.
  • Fourie, NH, Peace, RM, Abey, SK, Sherwin, LB, Wiley, JW, & Henderson, WA. (2016). Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform. J. Vis. Exp. (117), e54693, DOI: 10.3791/54693.
  • Fourie, NH, Wang, D, Abey, SK, Sherwin, LB, Joseph, PV, Rahim-Williams, B, Ferguson, EG & Henderson, Wa. (2016). The Microbiome of the Oral Mucosa in Irritable Bowel Syndrome. Gut Microbes. DOI: 10.1080/19490976.2016.1162363
  • Weaver, KR, Sherwin, LB, Walitt, B, Melkus, G, & Henderson, WA. (2016). Neuroimaging the Brain-Gut Axis in Patients with Irritable Bowel Syndrome. World Journal of Gastroenterology, 7(2), 320-333, DOI: 10.4292/wjgpt.v7i2.320
        •  

 

Selected Presentations
  • Sherwin, LB, Matteson-Kome, M, Bechtold, M, Reeder, B. Social Support Targeted Text Messages to Enhance Medication Adherence: preliminary results. ESPACOMP: International Society for Medication Adherence, Annual Conference, Virtual Conference, November 8-10th, 12th, 16-19th, 2021.
  • Sherwin, LB, #Yevu-Johnson, J, Matteson-Kome, M, Bechtold, M, & Reeder, B.  Remote usability testing to facilitate the continuation of research. One World, One Health: Global Partnership for Digital Innovation, International Medical Informatics Association Annual Conference, Virtual Conference, October 2-4, 2021.
  • Sherwin, L.B., Deroche, C.B., #Yevu-Johnson, J., Matteson-Kome, M., Bechtold, M., Jahnke, I., & Alexander, G.L.  Usability evaluation of a social support enhanced medication reminder smartphone application in adults with Irritable Bowel Syndrome. Midwest Nursing Research Society 45th Annual Research Conference, Virtual Conference, March 24-27, 2021, [Poster Presentation]
  • Sherwin, LB, Deroche, C, #Krisanabud, P, Matteson-Kome, M, Bechtold, M, Wakefield, B., & Ruppar, T (2019, August 15).  Patient perspectives on short-course pharmacotherapy: barriers and facilitators to rifaximin adherence.  American Neurogastroenterology and Motility Society Conference, Chicago, IL.  [Poster Presentation]
  • Sherwin, LB, Deroche, C, #Krisanabud, P, Matteson-Kome, M, Bechtold, M, Ruppar, T (2019 January 22).  Engaging patients to optimize medication adherence in irritable bowel syndrome.  PCORI Symposium, University of Missouri, Columbia, MO [Podium Presentation].
  • Sherwin, LB, Deroche, C, #Krisanabud, P, Matteson-Kome, M, Bechtold, M, Ruppar, T (2018 November 30).  Patient engagement and psychosocial determinants of rifaximin adherence in Irritable Bowel Syndrome.  European Society for Patient Adherence, Compliance, and Persistence (ESPACOMP), Dublin, Ireland [Podium Presentation].
  • Sherwin, LB, Deroche, C, #Krisanabud, P, Matteson-Kome, M, Bechtold, M, Ruppar, T (2018 August 30).  Psychosocial determinants of rifaximin adherence in Irritable Bowel Syndrome.  3rd Meeting of the Federation of Neurogastroenterology and Motility Society, Amsterdam, Netherlands [Poster Presentation].
  • Krisanabud, P, & Sherwin, LB, (2017 November 9).  The association between symptom severity and physical activity interference among irritable bowel syndrome patients [Poster].  Health Science Research Day, University of Missouri, Columbia, MO. Deans’ Award Recipient.
          •  

 

Link to CV Here